Pyrido[2,3-d]pyrimidin-7-one Inhibitors of Cyclin-Dependent Kinases
- 1 November 2000
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 43 (24) , 4606-4616
- https://doi.org/10.1021/jm000271k
Abstract
The identification of 8-ethyl-2-phenylamino-8H-pyrido[2,3-d]pyrimidin-7-one (1) as an inhibitor of Cdk4 led to the initiation of a program to evaluate related pyrido[2,3-d]pyrimidin-7-ones for inhibition of cyclin-dependent kinases (Cdks). Analysis of more than 60 analogues has identified some clear SAR trends that may be exploited in the design of more potent Cdk inhibitors. The most potent Cdk4 inhibitors reported in this study inhibit Cdk4 with IC50 = 0.004 μM ([ATP] = 25 μM). X-ray crystallographic analysis of representative compounds bound to the related kinase, Cdk2, reveals that they occupy the ATP binding site. Modest selectivity between Cdks is exhibited by some compounds, and Cdk4-selective inhibitors block pRb+ cells in the G1-phase of the cell division cycle.Keywords
This publication has 16 references indexed in Scilit:
- Targeting hyperproliferative disorders with cyclin dependent kinase inhibitorsExpert Opinion on Therapeutic Patents, 2000
- Novel drugs targeting the cell cycleEmerging Drugs, 2000
- CYCLINS AND CELL CYCLE CHECKPOINTSAnnual Review of Pharmacology and Toxicology, 1999
- The p21Cip1 and p27Kip1 CDK `inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblastsThe EMBO Journal, 1999
- Synthesis and Tyrosine Kinase Inhibitory Activity of a Series of 2-Amino-8H-pyrido[2,3-d]pyrimidines: Identification of Potent, Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase InhibitorsJournal of Medicinal Chemistry, 1998
- 2-Substituted Aminopyrido[2,3-d]pyrimidin-7(8H)-ones. Structure−Activity Relationships Against Selected Tyrosine Kinases and in Vitro and in Vivo Anticancer ActivityJournal of Medicinal Chemistry, 1998
- Development of a Binding Model to Protein Tyrosine Kinases for Substituted Pyrido[2,3-d]pyrimidine InhibitorsJournal of Medicinal Chemistry, 1998
- Cancer Cell CyclesScience, 1996
- High-Resolution Crystal Structures of Human Cyclin-Dependent Kinase 2 with and without ATP: Bound Waters and Natural Ligand as Guides for Inhibitor DesignJournal of Medicinal Chemistry, 1996
- Reductive cyclization of 2-[(2-propynyl)oxy]ethyl bromides by a cobalt complex, cobaloxime(I). A new method for the synthesis of .alpha.-methylene-.gamma.-butyrolactonesThe Journal of Organic Chemistry, 1982